Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Operating activities
Net income	$ 390,982	$ 120,462
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	24,581	25,382
Stock-based compensation	409,840	343,295
Noncash operating lease expense	32,041	34,810
Unrealized and realized (gain) loss from marketable securities, net	26,021	11,810
Noncash consideration	(34,789)	(34,852)
Other operating activities	19,115	(13,328)
Changes in operating assets and liabilities:
Accounts receivable, net	(311,699)	(159,752)
Prepaid expenses and other current assets	(19,547)	(75)
Other assets	4,056	1,941
Accounts payable	7,710	(32,387)
Accrued liabilities	42,149	2,552
Deferred revenue, current and noncurrent	(27,117)	64,464
Customer deposits, current and noncurrent	159,457	84,272
Operating lease liabilities, current and noncurrent	(35,205)	(37,767)
Other noncurrent liabilities	5,943	184
Net cash provided by operating activities	693,538	411,011
Investing activities
Purchases of property and equipment	(9,528)	(10,254)
Purchases of marketable securities	(3,418,699)	(4,791,670)
Proceeds from sales and redemption of marketable securities	2,451,378	2,608,898
Proceeds from sales of alternative investments	0	51,072
Other investing activities	4,000	0
Net cash used in investing activities	(980,849)	(2,141,954)
Financing activities
Proceeds from the exercise of common stock options	270,207	166,829
Repurchases of common stock	45,598	0
Other financing activities	91	778
Net cash provided by financing activities	224,700	167,607
Effect of foreign exchange on cash, cash equivalents, and restricted cash	960	(2,113)
Net decrease in cash, cash equivalents, and restricted cash	(61,651)	(1,565,449)
Cash, cash equivalents, and restricted cash - beginning of period	850,107	2,627,335
Cash, cash equivalents, and restricted cash - end of period	$ 788,456	$ 1,061,886